团队人员

1.   研究组长：池在龙研究员，医学博士，研究生导师。浙江省高校“钱江学者”特聘教授， 温州市“580海外精英引进计划”特聘专家，浙江省新世纪151人才工程第一层次培养人才。日本国立富山大学眼科学博士，日本学术振兴会外国人特别研究员，日本国立东京医疗中心研究员，美国哈佛医学院博士后。十二年的海外学习和工作后，于2014年回到温州医科大学组建实验室。参与眼科精准医疗学科创新引智基地“111”计划。

2.   工作人员：戴小丹、李童、刘西媛

研究方向

  1. 神经退行性眼病发病机制及其治疗新方法的开发

  2. 新生血管性眼病的发病机制研究及其干预治疗方法的开发

  3. 葡萄膜炎发病机制研究及其诊断技术和药物开发

Laboratory of Neurovascular Biology

Team members

1.       Principle Investigator: Zai-Long Chi, MD, PhD

Zai-Long Chi received his PhD degree in the Department of Ophthalmology at University of Toyama, Japan and immediately joined the National Hospital Organization Tokyo Medical Center as JSPS Fellow and investigator. Then, he joined at Harvard Medical School as research fellow. After 12 years overseas study and work, he returned to China in 2014 and established his own lab at Wenzhou Medical University. His research focuses on the major blindness eye diseases, such as glaucoma, age-related macular degeneration and uveitis to understand the mechanism of the disease onset. He is winner of “Qianjiang scholar” professorship and “580 Plan”, the first level of “151 talents project” in Zhejiang province. He participated in the State Bureau of higher school subject innovation engineering plan -“Precision Medicine of Ophthalmology”.

2.       Team Staff: XiaoDan Dai, Tong Li and XiYuan Liu

Scope of Research Proposal

1.       The pathogenesis of neurodegenerative diseases, discovery and development of the novel therapy

 2.     The pathogenesis of neovascular eye disease and the development of intervention therapy

      3.     The pathogenesis of uveitis and its diagnosis and therapy